# Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents

> **NCT02404779** · PHASE4 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 34 (estimated)

## Conditions studied

- Traumatic Brain Injury
- Intracranial Hypertension

## Interventions

- **DRUG:** cisatracurium besilate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02404779
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03-19
- **Primary completion:** 2022-03-19
- **Final completion:** 2022-06-18
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02404779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02404779, "Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02404779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*